Virtual cell predicts how close tumor environment influences cancer metastasis

March 31, 2020

Despite intensive research effort, the process of metastasis, which allows carcinoma cells to leave the tumor of origin, to migrate and to grow tumors within other organs, is still the leading cause of mortality for cancer patients. It is acknowledged that the acquisition of migrating capacities by cancer cells relies on a process called Epithelial to Mesenchymal Transition (EMT). During this process, cancer cells lose their ability to attach to other cells, become independent cells and gain abilities to migrate, thus switching from an epithelial state to a so-called mesenchymal state. However, this process seems to rarely complete, as many cancer cells maintain properties of both epithelial and mesenchymal cells. These hybrid cells may be the most dangerous ones, as they appear to survive treatments with chemotherapeutic drugs and to cause new tumors. A very large number of molecules or signals inside the cell has been shown to control this process. In addition, cells in the neighborhood of tumor cells, as well as the web of proteins on which cells are seated, called the extracellular matrix, send a multitude of signals to tumor cells to cause or prevent the EMT process. Yet it remains to be uncovered which of these molecular signals should be targeted to alt metastasis, to kill hybrid cancer cells and to prevent the formation of new tumors.

The large number of signals involved in metastasis is now far beyond the capability of any researcher to be integrated in order to predict how a cell will behave. To get around this problem, the research's groups lead by Claudine Chaouiya and Florence Janody at Instituto Gulbenkian de Ciências (IGC) and Instituto de Investigação e Inovação em Saúde (i3S) have built a virtual computational cell, with numerous molecules interacting with each other. This virtual cell can become epithelial, mesenchymal or hybrid cancer cell. It is also under the influence of many signals coming from outside the cell. According to Claudine Chaouiya "computational models permit to perform virtual experiments that are cheaper and faster than experiments with alive cells, to test hypotheses and to make predictions". Predictions given by the virtual cell were tested using alive human and canine cells. Among these predictions, Chaouiya and Janody research teams confirmed that hybrid cancer cells expressing the oncogene Src become mesenchymal if they are seated on a more rigid extracellular matrix. They have also discovered that, as predicted by the virtual cell, mesenchymal cancer cells expressing the oncogene Src become hybrid cancer cells when they contain the RPTP-kappa molecule, which connects cells to each other. Florence Janody explains that "experiments combining virtual and alive cells allowed us very efficiently to propose new ways by which we could prevent metastasis and the formation of new tumors".

This study demonstrates that collaborative efforts between mathematicians and biologists bring up a very powerful plan of attack to explain the behavior of cancer cells. This work has permitted to discover molecules and signals in the cell environment, which instruct cancer cells to migrate and invade the body. These signals could be used as targets for developing therapeutic strategies against cancer cells with these behaviors.

Instituto Gulbenkian de Ciencia

Related Cancer Cells Articles from Brightsurf:

Cancer researchers train white blood cells to attacks tumor cells
Scientists at the National Center for Tumor Diseases Dresden (NCT/UCC) and Dresden University Medicine, together with an international team of researchers, were able to demonstrate that certain white blood cells, so-called neutrophil granulocytes, can potentially - after completing a special training program -- be utilized for the treatment of tumors.

New way to target some rapidly dividing cancer cells, leaving healthy cells unharmed
Scientists at Johns Hopkins Medicine and the University of Oxford say they have found a new way to kill some multiplying human breast cancer cells by selectively attacking the core of their cell division machinery.

Breast cancer cells use message-carrying vesicles to send oncogenic stimuli to normal cells
According to a Wistar study, breast cancer cells starved for oxygen send out messages that induce oncogenic changes in surrounding normal epithelial cells.

Breast cancer cells turn killer immune cells into allies
Researchers at Johns Hopkins University School of Medicine have discovered that breast cancer cells can alter the function of immune cells known as Natural killer (NK) cells so that instead of killing the cancer cells, they facilitate their spread to other parts of the body.

Breast cancer cells can reprogram immune cells to assist in metastasis
Johns Hopkins Kimmel Cancer Center investigators report they have uncovered a new mechanism by which invasive breast cancer cells evade the immune system to metastasize, or spread, to other areas of the body.

Engineered immune cells recognize, attack human and mouse solid-tumor cancer cells
CAR-T therapy has been used successfully in patients with blood cancers such as lymphoma and leukemia.

Drug that keeps surface receptors on cancer cells makes them more visible to immune cells
A drug that is already clinically available for the treatment of nausea and psychosis, called prochlorperazine (PCZ), inhibits the internalization of receptors on the surface of tumor cells, thereby increasing the ability of anticancer antibodies to bind to the receptors and mount more effective immune responses.

Engineered bone marrow cells slow growth of prostate and pancreatic cancer cells
In experiments with mice, researchers at the Johns Hopkins Kimmel Cancer Center say they have slowed the growth of transplanted human prostate and pancreatic cancer cells by introducing bone marrow cells with a specific gene deletion to induce a novel immune response.

First phase i clinical trial of CRISPR-edited cells for cancer shows cells safe and durable
Following the first US test of CRISPR gene editing in patients with advanced cancer, researchers report these patients experienced no negative side effects and that the engineered T cells persisted in their bodies -- for months.

Zika virus' key into brain cells ID'd, leveraged to block infection and kill cancer cells
Two different UC San Diego research teams identified the same molecule -- αvβ5 integrin -- as Zika virus' key to brain cell entry.

Read More: Cancer Cells News and Cancer Cells Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to